Aurinia Pharmaceuticals (AUPH) Amortization - Intangibles (2020 - 2021)
Aurinia Pharmaceuticals (AUPH) reported Amortization - Intangibles of $524000.0 for Q4 2021, up 31.66% on a YoY basis from $398000.0 in Q4 2020, and up 1.35% quarter-over-quarter from $517000.0 in Q3 2021.
Aurinia Pharmaceuticals (AUPH) Amortization - Intangibles (2020 - 2021) Analysis & Trends
Aurinia Pharmaceuticals has reported Amortization - Intangibles for 2 years, with the latest figure at $524000.0 in Q4 2021.
- For the quarter ending Q4 2021, Amortization - Intangibles rose 31.66% year-over-year to $524000.0; the trailing twelve-month figure through Dec 2021 stood at $2.0 million (up 57.0% YoY), and the FY2021 full-year result was $2.1 million, up 61.54% from the prior year.
- Amortization - Intangibles for Q4 2021 stood at $524000.0, up from $517000.0 in the prior quarter.
- The five-year high for Amortization - Intangibles was $524000.0 in Q4 2021, with the low at $286000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Aurinia Pharmaceuticals | 2.18 Bn | 1.80 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 524,000.00 |
| Sep 30, 2021 | 517,000.00 |
| Jun 30, 2021 | 500,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Dec 31, 2020 | 398,000.00 |
| Sep 30, 2020 | 316,000.00 |
| Jun 30, 2020 | 300,000.00 |
| Mar 31, 2020 | 286,000.00 |